Modified vaccinia virus Ankara as vaccine vectors in human and veterinary medicine

dc.creatorQuinan, Bárbara Resende
dc.creatorDaian, Danielle Soares de Oliveira
dc.creatorCoelho, Fabiana Magalhães
dc.creatorFonseca, Flávio Guimarães da
dc.date2015-07-15T18:31:26Z
dc.date2015-07-15T18:31:26Z
dc.date2014
dc.date.accessioned2023-09-26T22:53:10Z
dc.date.available2023-09-26T22:53:10Z
dc.identifierQUINAN, Bárbara Resende et al. Modified vaccinia virus Ankara as vaccine vectors in human and veterinary medicine. Future Virology. Vol. 9, No. 2, p. 173-187, 2014
dc.identifier1746-0794
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/11385
dc.identifier10.2217/fvl.13.129 10.2217/fvl.13.129
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8884366
dc.descriptionDisease prevention through vaccination is one of the most important achievements of medicine. Today, we have a substantial number of vaccines against a variety of pathogens. In this context, poxviruses and vaccinology are closely related, as the birth of modern vaccinology was marked by the use of poxviruses as immunogens and so was the eradication of smallpox, one of the world's most feared diseases ever. Nowadays, poxviruses continue to notoriously contribute to vaccinology since their use as vaccine vectors has become popular and widespread. One of the most promising vectors is the modified vaccinia ankara. In this review we provide an overview of the contribution of poxvirus to vaccine immunology, particularly focusing on modified vaccinia ankara-based vaccines developed to date.
dc.formatapplication/pdf
dc.languageeng
dc.publisherFuture Medicine Ltd
dc.rightsrestricted access
dc.subjecthuman vaccines
dc.subjectMVA
dc.subjectrecombinant MVA
dc.subjectpoxvirus
dc.subjectvaccine
dc.subjectvaccinia virus
dc.subjectveterinary vaccines
dc.subjectviral vectors
dc.titleModified vaccinia virus Ankara as vaccine vectors in human and veterinary medicine
dc.typeArticle


Este ítem pertenece a la siguiente institución